Literature DB >> 21441493

Innate immunity including epithelial and nonspecific host factors: workshop 1B.

A Weinberg1, J R Naglik, A Kohli, S M Tugizov, P L Fidel, Y Liu, M Herzberg.   

Abstract

The majority of HIV infections are initiated at mucosal sites. The oral mucosal tissue has been shown to be a potential route of entry in humans and primates. Whereas HIV RNA, proviral DNA, and infected cells are detected in the oral mucosa and saliva of infected individuals, it appears that the oral mucosa is not permissive for efficient HIV replication and therefore may differ in susceptibility to infection when compared to other mucosal sites. Since there is no definitive information regarding the fate of the HIV virion in mucosal epithelium, there is a pressing need to understand what occurs when the virus is in contact with this tissue, what mechanisms are in play to determine the outcome, and to what degree the mechanisms and outcomes differ between mucosal sites. Workshop 1B tackled 5 important questions to define current knowledge about epithelial cell-derived innate immune agents, commensal and endogenous pathogens, and epithelial cells and cells of the adaptive immune system and how they contribute to dissemination or resistance to HIV infection. Discovering factors that explain the differential susceptibility and resistance to HIV infection in mucosal sites will allow for the identification and development of novel protective strategies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21441493      PMCID: PMC6699119          DOI: 10.1177/0022034511399917

Source DB:  PubMed          Journal:  Adv Dent Res        ISSN: 0895-9374


  73 in total

Review 1.  Subclinical chorioamnionitis as a targetable risk factor for vertical transmission of HIV-1.

Authors:  J S Stringer; R L Goldenberg
Journal:  Ann N Y Acad Sci       Date:  2000-11       Impact factor: 5.691

2.  In situ PCR detection of HIV expression in the human placenta.

Authors:  A U Sheikh; B M Polliotti; R K Miller
Journal:  Methods Mol Biol       Date:  2000

3.  Growth inhibition of Candida by human oral epithelial cells.

Authors:  C Steele; J Leigh; R Swoboda; P L Fidel
Journal:  J Infect Dis       Date:  2000-10-09       Impact factor: 5.226

4.  Productive human immunodeficiency virus-1 infection of epithelial cell lines of salivary gland origin.

Authors:  Y Han; C L Ventura; K P Black; J E Cummins; S D Hall; S Jackson
Journal:  Oral Microbiol Immunol       Date:  2000-04

Review 5.  Endogenous mucosal antiviral factors of the oral cavity.

Authors:  D C Shugars
Journal:  J Infect Dis       Date:  1999-05       Impact factor: 5.226

6.  TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression.

Authors:  B R Lane; D M Markovitz; N L Woodford; R Rochford; R M Strieter; M J Coffey
Journal:  J Immunol       Date:  1999-10-01       Impact factor: 5.422

Review 7.  Mastitis and transmission of human immunodeficiency virus through breast milk.

Authors:  R D Semba
Journal:  Ann N Y Acad Sci       Date:  2000-11       Impact factor: 5.691

Review 8.  Genital tract infections and perinatal transmission of HIV.

Authors:  T E Taha; R H Gray
Journal:  Ann N Y Acad Sci       Date:  2000-11       Impact factor: 5.691

9.  Subclinical mastitis as a risk factor for mother-infant HIV transmission.

Authors:  J F Willumsen; S M Filteau; A Coutsoudis; K E Uebel; M L Newell; A M Tomkins
Journal:  Adv Exp Med Biol       Date:  2000       Impact factor: 2.622

10.  The role of gammadelta T cells in generating antiviral factors and beta-chemokines in protection against mucosal simian immunodeficiency virus infection.

Authors:  T Lehner; E Mitchell; L Bergmeier; M Singh; R Spallek; M Cranage; G Hall; M Dennis; F Villinger; Y Wang
Journal:  Eur J Immunol       Date:  2000-08       Impact factor: 5.532

View more
  5 in total

Review 1.  Oral innate immunity in HIV infection in HAART era.

Authors:  Wipawee Nittayananta; Renchuan Tao; Lanlan Jiang; Yuanyuan Peng; Yuxiao Huang
Journal:  J Oral Pathol Med       Date:  2015-01-31       Impact factor: 4.253

2.  Comorbidities associated with HIV and antiretroviral therapy (clinical sciences): a workshop report.

Authors:  L T Vernon; Plp Jayashantha; M M Chidzonga; M C Komesu; R G Nair; N W Johnson
Journal:  Oral Dis       Date:  2016-04       Impact factor: 3.511

3.  Human beta-defensins 2 and -3 cointernalize with human immunodeficiency virus via heparan sulfate proteoglycans and reduce infectivity of intracellular virions in tonsil epithelial cells.

Authors:  Rossana Herrera; Michael Morris; Kristina Rosbe; Zhimin Feng; Aaron Weinberg; Sharof Tugizov
Journal:  Virology       Date:  2015-11-02       Impact factor: 3.616

4.  Oral and vaginal epithelial cell lines bind and transfer cell-free infectious HIV-1 to permissive cells but are not productively infected.

Authors:  Arinder Kohli; Ayesha Islam; David L Moyes; Celia Murciano; Chengguo Shen; Stephen J Challacombe; Julian R Naglik
Journal:  PLoS One       Date:  2014-05-23       Impact factor: 3.240

5.  Viral Infections During Pregnancy: The Big Challenge Threatening Maternal and Fetal Health.

Authors:  Wenzhe Yu; Xiaoqian Hu; Bin Cao
Journal:  Matern Fetal Med       Date:  2021-12-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.